Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides.

Hansson M, Mathsson L, Schlederer T, Israelsson L, Matsson P, Nogueira L, Jakobsson PJ, Lundberg K, Malmström V, Serre G, Holmdahl R, Nystrand M, Klareskog L, Rönnelid J.

Arthritis Res Ther. 2012 Oct 1;14(5):R201. doi: 10.1186/ar4039.

2.

Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.

Derganova O, Martinez-Gamboa L, Egerer K, Bang H, Fredenhagen G, Roggenbuck D, Esaulenko I, Burmester GR, Chernykh T, Feist E.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):622-9. Epub 2014 Sep 5.

PMID:
25189876
3.

Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.

Ossipova E, Cerqueira CF, Reed E, Kharlamova N, Israelsson L, Holmdahl R, Nandakumar KS, Engström M, Harre U, Schett G, Catrina AI, Malmström V, Sommarin Y, Klareskog L, Jakobsson PJ, Lundberg K.

Arthritis Res Ther. 2014 Aug 12;16(4):R167. doi: 10.1186/ar4683.

4.

Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.

Wagner CA, Sokolove J, Lahey LJ, Bengtsson C, Saevarsdottir S, Alfredsson L, Delanoy M, Lindstrom TM, Walker RP, Bromberg R, Chandra PE, Binder SR, Klareskog L, Robinson WH.

Ann Rheum Dis. 2015 Mar;74(3):579-86. doi: 10.1136/annrheumdis-2013-203915. Epub 2013 Dec 2.

5.

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.

Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, Lundberg K, Engström A, Venables PJ, Toes RE, Holmdahl R, Klareskog L, Malmström V.

Arthritis Rheum. 2010 Jan;62(1):44-52. doi: 10.1002/art.25036.

6.

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.

van Heemst J, Trouw LA, Nogueira L, van Steenbergen HW, van der Helm-van Mil AH, Allaart CF, Serre G, Holmdahl R, Huizinga TW, Toes RE, van der Woude D.

Arthritis Res Ther. 2015 Oct 5;17:276. doi: 10.1186/s13075-015-0786-z.

7.

Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?

Vannini A, Cheung K, Fusconi M, Stammen-Vogelzangs J, Drenth JP, Dall'Aglio AC, Bianchi FB, Bakker-Jonges LE, van Venrooij WJ, Pruijn GJ, Zendman AJ.

Ann Rheum Dis. 2007 Apr;66(4):511-6. Epub 2006 Sep 19.

8.

Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens.

Fernandes-Cerqueira C, Ossipova E, Gunasekera S, Hansson M, Mathsson L, Catrina AI, Sommarin Y, Klareskog L, Lundberg K, Rönnelid J, Göransson U, Jakobsson PJ.

Arthritis Res Ther. 2015 Jun 10;17:155. doi: 10.1186/s13075-015-0666-6.

9.

Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.

Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Rönnelid J, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2011 Feb 3;13(1):R13. doi: 10.1186/ar3237.

10.

Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles.

van Beers JJ, Willemze A, Stammen-Vogelzangs J, Drijfhout JW, Toes RE, Pruijn GJ.

Arthritis Res Ther. 2012 Feb 17;14(1):R35. doi: 10.1186/ar3744.

11.

Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.

Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engström A, Venables PJ, Lundeberg J, Holmdahl R, Klareskog L, Malmström V.

Ann Rheum Dis. 2009 May;68(5):736-43. doi: 10.1136/ard.2008.091355. Epub 2008 Jul 17.

PMID:
18635594
12.
13.

Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps.

Pratesi F, Dioni I, Tommasi C, Alcaro MC, Paolini I, Barbetti F, Boscaro F, Panza F, Puxeddu I, Rovero P, Migliorini P.

Ann Rheum Dis. 2014 Jul;73(7):1414-22. doi: 10.1136/annrheumdis-2012-202765. Epub 2013 Jun 1.

PMID:
23727635
14.

Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.

Goules JD, Goules AV, Tzioufas AG.

Clin Exp Immunol. 2013 Oct;174(1):10-7. doi: 10.1111/cei.12145.

15.

Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.

Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.

J Rheumatol. 2007 Aug;34(8):1658-63. Epub 2007 Jul 1.

PMID:
17611988
16.

The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.

Cornillet M, Sebbag M, Verrouil E, Magyar A, Babos F, Ruyssen-Witrand A, Hudecz F, Cantagrel A, Serre G, Nogueira L.

Ann Rheum Dis. 2014 Jun;73(6):1246-52. doi: 10.1136/annrheumdis-2012-202868. Epub 2013 May 1.

PMID:
23636655
17.

Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.

Schwenzer A, Jiang X, Mikuls TR, Payne JB, Sayles HR, Quirke AM, Kessler BM, Fischer R, Venables PJ, Lundberg K, Midwood KS.

Ann Rheum Dis. 2016 Oct;75(10):1876-83. doi: 10.1136/annrheumdis-2015-208495. Epub 2015 Dec 9.

18.

Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.

Brink M, Verheul MK, Rönnelid J, Berglin E, Holmdahl R, Toes RE, Klareskog L, Trouw LA, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2015 Feb 7;17:25. doi: 10.1186/s13075-015-0536-2.

19.

Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.

Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R; Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators.

Autoimmun Rev. 2012 Sep;11(11):815-20. doi: 10.1016/j.autrev.2012.02.015. Epub 2012 Feb 27.

PMID:
22394488
20.

Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.

Martínez G, Gómez JA, Bang H, Martínez-Gamboa L, Roggenbuck D, Burmester GR, Torres B, Prada D, Feist E.

Rheumatol Int. 2016 Jun;36(6):781-91. doi: 10.1007/s00296-016-3472-9. Epub 2016 Apr 2.

Supplemental Content

Support Center